ITG BRANDS, LLC (FORMERLY FONTEM US, INC.) for ITG BRANDS, LLC (FORMERLY FONTEM US, INC.)
What was lobbied
7 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Tobacco TOB
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Taxation/Internal Revenue Code TAX
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Budget/Appropriations BUD
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Consumer Issues/Safety/Products CSP
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Advertising ADV
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Manufacturing MAN
Equal treatment in regard to the "pre-market authorization" under FDA regulations as was allowed for combustible cigarettes and other listed tobacco products which were also already on the market at time of regulatory oversight enactment.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAMELA GORMAN New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| FONTEM VENTURES, B.V. | Netherlands | Netherlands | 100.0% | $2,500 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.